These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9306041)

  • 1. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
    Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
    Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure.
    Fukui M; Nakano K; Maruya E; Saji H; Ohta K; Ohta M; Obayashi H; Mori H; Kajiyama S; Wada S; Shigeta H; Kitagawa Y; Nakamura N; Kondo M
    Clin Immunol Immunopathol; 1997 Nov; 85(2):182-6. PubMed ID: 9344701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
    Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
    Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.
    Rattarasarn C; Diosdado MA; Ortego J; Leelawattana R; Soonthornpun S; Setasuban W; Jaruratanasirikul S; Patarakijvanich N
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):107-11. PubMed ID: 10963821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
    Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
    Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
    Panz VR; Kalk WJ; Zouvanis M; Joffe BI
    Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
    Takino H; Yamasaki H; Abiru N; Sera Y; Abe T; Kawasaki E; Yamaguchi Y; Eguchi K; Kanazawa Y; Nagataki S
    Diabet Med; 2002 Sep; 19(9):730-4. PubMed ID: 12207808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.
    Zhou Z; Ouyang L; Peng J; Yang W; Wang J; Zhu X; Wu H; Dyrberg T
    Chin Med J (Engl); 1999 Jun; 112(6):554-7. PubMed ID: 11601338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
    Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
    Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
    Nagai T; Imamura M; Mori M
    Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for latent autoimmune diabetes (LADA) in adults.
    Brophy S; Brunt H; Davies H; Mannan S; Williams R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto-antibodies in Japanese patients with non-insulin-dependent diabetes mellitus.
    Maruyama T; Kasuga A; Ozawa Y; Nagata A; Abiko F; Suzuki Y; Saruta T
    Endocr J; 1997 Feb; 44(1):43-51. PubMed ID: 9152613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C; Diosdado MA
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
    Yang L; Zhou ZG; Huang G; Yan X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.